Adage Capital Partners’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.5M Sell
6,601,938
-1,500,160
-19% -$3.06M 0.02% 550
2025
Q1
$10.8M Sell
8,102,098
-1,500,182
-16% -$2M 0.02% 570
2024
Q4
$25.4M Buy
9,602,280
+5,976,813
+165% +$15.8M 0.04% 376
2024
Q3
$6.6M Hold
3,625,467
0.01% 684
2024
Q2
$6.02M Hold
3,625,467
0.01% 689
2024
Q1
$8.3M Hold
3,625,467
0.02% 631
2023
Q4
$7.18M Hold
3,625,467
0.01% 646
2023
Q3
$4.71M Hold
3,625,467
0.01% 671
2023
Q2
$5.87M Hold
3,625,467
0.01% 651
2023
Q1
$7.72M Hold
3,625,467
0.02% 660
2022
Q4
$13.4M Buy
3,625,467
+325,467
+10% +$1.2M 0.03% 557
2022
Q3
$2.46M Hold
3,300,000
0.01% 842
2022
Q2
$2.57M Hold
3,300,000
0.01% 866
2022
Q1
$2.99M Sell
3,300,000
-1,415,152
-30% -$1.28M 0.01% 874
2021
Q4
$37.8M Hold
4,715,152
0.07% 292
2021
Q3
$39.5M Buy
4,715,152
+20,687
+0.4% +$173K 0.08% 257
2021
Q2
$31.6M Hold
4,694,465
0.06% 326
2021
Q1
$31M Buy
4,694,465
+144,403
+3% +$954K 0.06% 320
2020
Q4
$19.1M Hold
4,550,062
0.04% 424
2020
Q3
$21.8M Hold
4,550,062
0.05% 352
2020
Q2
$27.7M Hold
4,550,062
0.07% 305
2020
Q1
$25M Sell
4,550,062
-21,257
-0.5% -$117K 0.07% 273
2019
Q4
$45.3M Buy
4,571,319
+835,812
+22% +$8.28M 0.11% 225
2019
Q3
$21.5M Hold
3,735,507
0.05% 349
2019
Q2
$34M Hold
3,735,507
0.08% 266
2019
Q1
$51.8M Hold
3,735,507
0.13% 194
2018
Q4
$58.9M Buy
3,735,507
+273,566
+8% +$4.32M 0.16% 164
2018
Q3
$67M Buy
3,461,941
+1,299,414
+60% +$25.1M 0.15% 172
2018
Q2
$15.8M Buy
2,162,527
+662,527
+44% +$4.84M 0.04% 464
2018
Q1
$4.61M Buy
1,500,000
+500,000
+50% +$1.54M 0.01% 644
2017
Q4
$3.23M Buy
+1,000,000
New +$3.23M 0.01% 649